Reonam Injection

About Reonam 500 mg/vial Injection

Reonam 500 mg/vial Injection is manufactured by Advanced Chemical Industries PLC and contains aztreonam, a beta-lactam antibiotic. It is given by injection to treat certain bacterial infections.

There are 5 brands of Aztreonam listed in Bangladesh. The lowest listed price is Azactum 1 gm/5 ml IM/IV Injection at ৳ 400.00 per unit.

What is Reonam 500 mg/vial Injection?

Reonam 500 mg/vial Injection is an antibiotic medicine from Advanced Chemical Industries PLC. It contains aztreonam, which belongs to a group called beta-lactam antibiotics. It works by interfering with the building of the bacterial cell wall, which can stop the growth of certain bacteria. It is used for infections caused by susceptible aerobic Gram-negative bacteria. It comes as a powder that is made into a solution for injection by a healthcare professional. The dose and course are decided by the doctor based on the infection and the patient's condition.

Uses of Reonam

Reonam Injection is used to treat infections caused by certain Gram-negative bacteria that are susceptible to aztreonam. These include urinary tract infections such as pyelonephritis and cystitis, and gonorrhea. It may also be used for other infections as determined by the doctor. It is not effective against viruses or all types of bacteria. The doctor will decide if this medicine is suitable for a particular infection.

How to use Reonam

Reonam Injection is given by a healthcare professional, usually by injection into a vein or muscle. It is not for self-administration at home. The dose, frequency, and duration are decided by the doctor based on the type and severity of infection, the patient's age and kidney function, and other factors. The doctor or pharmacist will explain how it will be given. Do not attempt to use it without medical supervision.

Side effects of Reonam

Like all medicines, Reonam Injection can cause side effects. Local reactions at the injection site, such as discomfort, swelling, or vein inflammation, may occur. Other possible side effects include diarrhea, nausea, vomiting, and rash. More serious reactions such as allergic reactions, blood cell changes, and seizures have been reported. If you notice any unusual symptoms during treatment, tell your doctor or nurse right away.

Safety and precautions

Before receiving Reonam Injection, tell your doctor if you are allergic to aztreonam or any other antibiotic, or if you have liver or kidney problems. The doctor may monitor you more closely if you have impaired liver or kidney function. If you are pregnant or breastfeeding, discuss with your doctor; this medicine should be used during pregnancy only if clearly needed, and temporary stopping of breastfeeding may be advised. The doctor will decide if it is right for you.

Frequently asked questions

How should Reonam Injection be stored?

Store it in a cool and dry place, away from light and moisture. Keep all medicines out of reach of children. The healthcare professional will prepare and store the injection as required. Do not use it if the solution appears discolored or contains particles.

What is Reonam Injection used for and what kind of medicine is it?

Reonam Injection is an antibiotic (a beta-lactam) used to treat certain bacterial infections caused by susceptible Gram-negative bacteria, such as urinary tract infections and gonorrhea. It is not for viral infections. Your doctor will decide if it is appropriate for your condition.

What does the dosage form and strength mean for Reonam Injection?

It is supplied as a powder for injection in a vial containing 500 mg of aztreonam. A healthcare professional will dissolve it to make a solution for injection. The dose and course are determined by the doctor; do not use it on your own.

Who should ask a doctor before using Reonam Injection?

Anyone with a known allergy to aztreonam or other beta-lactam antibiotics, liver or kidney problems, or who is pregnant or breastfeeding should consult a doctor first. The doctor will assess the risks and benefits and decide if this medicine is suitable.

Indications

Aztreonam is indicated in the treatment of the following infections caused by susceptible aerobic Gram-negative micro-organisms

Urinary tract infections: Pyelonephritis, cystitis (initial and recurrent) and asymptomatic bacteriuria (including those due to pathogens resistant ... Read moreAztreonam is indicated in the treatment of the following infections caused by susceptible aerobic Gram-negative micro-organisms

Urinary tract infections: Pyelonephritis, cystitis (initial and recurrent) and asymptomatic bacteriuria (including those due to pathogens resistant to the aminoglycosides, cephalosporins or penicillins).
Gonorrhea: Acute uncomplicated urogenital or anorectal infections.
Lower respiratory tract infections: Including pneumonia, bronchitis and lung infections in patients with cystic fibrosis.
Skin and soft tissue infections: Postoperative wounds, ulcers and burns.
Meningitis: Caused by Haemophilusinfluenzae or Neisseria meningitidis.
Gynecological infections: Pelvic Inflammatory Disease (PID), endometritis and pelvic cellulitis.
Intra-abdominal infections: Peritonitis.
Bacteremia/ septicemia: Septicemia caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa,Proteus mirabilis, Serratia marcescens and Enterobacter species.
Bone and joint infections: Osteomyelitis,septic arthritis.

Aztreonam is also indicated for adjunctive therapy to surgery in the management of infections caused by susceptible organisms. Patients with serious Pseudomonas infections may benefit from concurrent use of Aztreonam and an aminoglycoside because of their synergistic action.

Pharmacology

Aztreonam is a synthetic bactericidal monobactam antibiotic. It inhibits bacterial cell wall synthesis by blocking peptidoglycan crosslinking. The inhibition of bacterial cell wall synthesis occurs due to a high affinity of Aztreonam for penicillin binding protein 3 (PBP3). By binding to PBP3, Aztreonam inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that Aztreonam interferes with an autolysin inhibitor.

Dosage & Administration

Adults: The usual dose of Aztreonam is 3 to 4 gm daily (maximum recommended dose is 8 gm daily). The dosage and route of administration should be determined by the susceptibility of the causative organisms, severity of infection and the condition of the patient. In case of Pseudomonas aeruginosa infections, 2 gm every 6 or 8 hours is recommended.

Children: The usual dosage for patients older than one week is 30 mg/kg/dose every 6 or 8 hours. For severe infections in patients 2 years of age or older, 50 mg/kg/dose every 6 or 8 hours is recommended.Dosage information is not yet available for new-born less than 1 week old.

Dosage Guideline for adult:

  • Urinary tract infections: 500 mg or 1 gm; 8 or 12 hourly
  • Moderately severe systemic infections: 1 g or 2 gm; 8 or 12 hourly
  • Severe systemic or life-threatening infections: 2 gm; 6 or 8 hourly
  • Maximum recommended dose is 8 gm/ day.
Dosage Guideline or pediatric:
  • Mild to moderate infections: 30 mg/kg; 8 hourly
  • Moderate to severe infections (2 years or older): 50 mg/kg; 6 or 8 hourly
  • Maximum recommended dose is 120 mg/ kg/ day.

Interaction

Concomitant administration of probenecid or furosemide and Aztreonam causes clinically insignificant increases in the serum levels of Aztreonam.

Contraindications

This preparation is contraindicated in patients with known hypersensitivity to Aztreonam or any other component in the formulation.

Side Effects

Local reactions such as phlebitis/thrombophlebitis following IV administration and discomfort/swelling at the injection site following IM administration may occur. Systemic reactions like diarrhea, nausea and/or vomiting, and rash may occur. Other side effects include anaphylaxis, angioedema, bronchospasm, pancytopenia, neutropenia, thrombocytopenia, anemia, eosinophilia, leukocytosis, thrombocytosis, abdominal cramps, dermatitis, urticaria, pruritus, hypotension, flushing, seizure, weakness, headache, fever, malaise may occur.

Pregnancy & Lactation

Pregnancy Category B. Aztreonam crosses the placenta and enters the fetal circulation. So it should be used during pregnancy only if the potential benefit justifies the potential risk.

Aztreonam is excreted in breast milk in concentrations that are less than 1% of concentrations determined in simultaneously obtained maternal serum. Temporary discontinuation of nursing is recommended.

Precautions & Warnings

In patients with impaired hepatic or renal function, appropriate monitoring is recommended during therapy.

Overdose Effects

If necessary, Aztreonam may be cleared from the serum by hemodialysis and/or peritoneal dialysis.

Storage Conditions

Store in a cool & dry place, protected from light & moisture. Keep all medicines out of reach of children.

Alternative brands of Aztreonam

Other brands with the same generic name, cheapest first.

Azactum IM/IV Injection

1 gm/5 ml

Aztreonam

Drug International Ltd.

৳ 392 ৳ 400.00 2% off per unit

Azonam IM/IV Injection

1 gm/5 ml

Aztreonam

Incepta Pharmaceuticals Ltd.

৳ 392 ৳ 400.00 2% off per unit

Reonam IV/IM Injection

1 gm/vial

Aztreonam

Advanced Chemical Industries PLC

Price not listed

Reonam Injection

2 gm/vial

Aztreonam

Advanced Chemical Industries PLC

Price not listed

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.